APA aipamena

Lawn, S. D., Myer, L., Bangani, N., Vogt, M., & Wood, R. (2007). Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa. BioMed Central.

Chicago Style aipamena

Lawn, Stephen D., Landon Myer, Nonzwakazi Bangani, Monica Vogt, and Robin Wood. Plasma Levels of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Early Mortality Risk Among Patients Enrolling for Antiretroviral Treatment in South Africa. BioMed Central, 2007.

MLA aipamena

Lawn, Stephen D., et al. Plasma Levels of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Early Mortality Risk Among Patients Enrolling for Antiretroviral Treatment in South Africa. BioMed Central, 2007.